How do we get these numbers?
23andMe is a registered trademark of 23andMe, Inc. The use of the name and logo are for compatibility information only and does not imply approval or endorsement of Sequencing.com by 23andMe, Inc.
How do we get these numbers?
23andMe is a registered trademark of 23andMe, Inc. The use of the name and logo are for compatibility information only and does not imply approval or endorsement of Sequencing.com by 23andMe, Inc.
DNA tests from 23andMe, AncestryDNA, and most other companies use older technology that produces data on a very small subset of the total genome.
Whole genome sequencing is an entirely different class of technology that tests every letter of your DNA, including all ~30,000 genes and all chromosomes end-to-end.
0.1%
100%
Of Your Genome
Of Your Genome
DNA tests from 23andMe, AncestryDNA, and most other companies use older technology that produces data on a very small subset of the total genome.
Whole genome sequencing is an entirely different class of technology that tests every letter of your DNA, including all ~30,000 genes and all chromosomes end-to-end.
0.1%
100%
Of Your Genome
Of Your Genome
Start by ordering the world’s most comprehensive DNA test kit.
Start by ordering the world’s most comprehensive DNA test kit.
Whole Genome Sequencing
Rare Disease Bundle
$399 $639
Privacy First Data Protection
We don’t sell or share your data with anyone.
Obtains data on around 3 billion positions within your genome (100% of your genome). Also includes the ability to download your raw genome data files for no additional fee. This includes FASTQ, BAM and VCFs covering all genetic variations: Single Nucleotide Polymorphisms (SNPs), Insertions and Deletions (INDELs), Structural Variations (SVs), Copy Number Variations (CNVs) and Mitochondrial Heteroplasmy (MITO).
Next-Gen Rare Disease Screen WGS Bundle
$399 $789
INCLUDES:
Full Access To All Raw Genome Data & Analyzed Data:
3 billion genetic variants
All 30,000 genes sequenced
All chromosomes fully sequenced incl. the mitochondrial & Y chromosomes
100% of your genome
30x genome sequencing
Whole Genome Sequencing
One Month Premium Genome Plan
Standard Processing
Next-Gen Rare Disease Screen
Genome Explorer
SequencingAI
Next-Gen Rare Disease Screen WGS Bundle
$399 $789
INCLUDES:
One Month Premium Genome Plan
Whole Genome Sequencing
Full Access To All Raw Genome Data & Analyzed Data:
3 billion genetic variants
All 30,000 genes sequenced
All chromosomes fully sequenced including the mitochondrial & Y chromosomes
100% of your genome
30x genome sequencing depth
Standard Processing
Next-Gen Disease Screen
SequencingAI
Genome Explorer
Obtains data on around 3 billion positions within your genome (100% of your genome). Also includes the ability to download your raw genome data files for no additional fee. This includes FASTQ, BAM and VCFs covering all genetic variations: Single Nucleotide Polymorphisms (SNPs), Insertions and Deletions (INDELs), Structural Variations (SVs), Copy Number Variations (CNVs) and Mitochondrial Heteroplasmy (MITO).
World's Most Comprehensive Rare Disease Screening
23andMe is a registered trademark of 23andMe, Inc., AncestryDNA is a registered trademark of Ancestry Operations Inc. dba Ancestry, Family Tree DNA is a registered trademark of Gene By Gene, Ltd., MyHeritage is a registered trademark of MyHeritage Ltd., Dante Labs is a registered trademark of Dante Labs, Inc., Nebula Genomics is a registered trademark of Nebula Genomics, Inc., HomeDNA is a trademark of DNA Diagnostic Center, Inc., Living DNA is a registered trademark of Living DNA Ltd., Vitagene is a registered trademark of Vitagene, Inc. The use of the name and logo are for compatibility information only and does not imply approval or endorsement of Sequencing.com by 23andMe, Inc., Ancestry Operations Inc. dba Ancestry, Gene By Gene, Ltd., MyHeritage Ltd., Dante Labs, Inc., Nebula Genomics, Inc., DNA Diagnostic Center, Inc., Living DNA Ltd., or Vitagene, Inc.
23andMe is a registered trademark of 23andMe, Inc., AncestryDNA is a registered trademark of Ancestry Operations Inc. dba Ancestry, Family Tree DNA is a registered trademark of Gene By Gene, Ltd., MyHeritage is a registered trademark of MyHeritage Ltd., Dante Labs is a registered trademark of Dante Labs, Inc., Nebula Genomics is a registered trademark of Nebula Genomics, Inc., HomeDNA is a trademark of DNA Diagnostic Center, Inc., Living DNA is a registered trademark of Living DNA Ltd., Vitagene is a registered trademark of Vitagene, Inc. The use of the name and logo are for compatibility information only and does not imply approval or endorsement of Sequencing.com by 23andMe, Inc., Ancestry Operations Inc. dba Ancestry, Gene By Gene, Ltd., MyHeritage Ltd., Dante Labs, Inc., Nebula Genomics, Inc., DNA Diagnostic Center, Inc., Living DNA Ltd., or Vitagene, Inc.
Screening Includes The KLK15 Gene Variant, Linked Preliminarily To hEDS*
No Insurance Companies
Keep Your Results Anonymous
Save Thousands Without A Doctor's Lab Order
Working directly with CLIA-certified labs for clinical-grade 30x Sequencing.
Meet The Families In Need
In honor of Rare Disease Day, we invite you to be part of a special initiative:
For every 50 Rare Disease Day WGS Special Bundles ordered, we pledge to donate a bundle to a family grappling with unresolved health mysteries. These families in need stand to gain invaluable insights from genome sequencing, offering them a beacon of hope in their search for answers.
Dr. Brandon Colby, founder of Sequencing.com, navigated through a challenging childhood plagued by a mysterious health condition—extensive blistering on his feet and hands, with no diagnosis in sight despite countless medical consultations and tests. His significant discovery was made possible by merging whole genome sequencing with the innovative Next-Gen Disease Screen (NGDS), a combination beyond the capability of any other existing test. This powerful approach finally uncovered the genetic culprit: a mutation in the KRT14 gene.
This breakthrough not only provided Dr. Colby with much-needed clarity but also allowed him and his wife to make informed decisions about their family's future, understanding the implications of their genetic makeup. Dr. Colby's experience highlights the transformative impact of NGDS, showcasing its potential to replace fear and uncertainty with empowerment and precise genetic knowledge.
Meet The Families In Need
In honor of Rare Disease Day, we invite you to be part of a special initiative:
For every 50 Rare Disease Day WGS Special Bundles ordered, we pledge to donate a bundle to a family grappling with unresolved health mysteries. These families in need stand to gain invaluable insights from genome sequencing, offering them a beacon of hope in their search for answers.
Traditional labs charge thousands of dollars to test for a single disease, and at most, up to 30 diseases. These expensive tests often only scratch the surface of your genes, leaving a wealth of crucial information untouched.
NGDS is here to change that narrative. Analyzing whole genome sequencing data, NGDS provides a straightforward assessment of your genetic risk for more than 15,000 diseases, conditions, traits, and medication reactions. This transformative tool enables you to screen your entire genome for almost every disease with a known genetic component.
extensive blistering on his feet and hands, with no diagnosis in sight despite countless medical consultations and tests. His significant discovery was made possible by merging whole genome sequencing with the innovative Next-Gen Disease Screen (NGDS), a combination beyond the capability of any other existing test. This powerful approach finally uncovered the genetic culprit: a mutation in the KRT14 gene.
This breakthrough not only provided Dr. Colby with much-needed clarity but also allowed him and his wife to make informed decisions about their family's future, understanding the implications of their genetic makeup. Dr. Colby's experience highlights the transformative impact of NGDS, showcasing its potential to replace fear and uncertainty with empowerment and precise genetic knowledge.
Dr. Brandon Colby, founder of Sequencing.com, navigated through a challenging childhood plagued by a mysterious health condition—
Traditional labs charge thousands of dollars to test for a single disease, and at most, up to 30 diseases. These expensive tests often only scratch the surface of your genes, leaving a wealth of crucial information untouched.
Dr. Brandon Colby, founder of Sequencing.com, navigated through a challenging childhood plagued by a mysterious health condition—extensive blistering on his feet and hands, with no diagnosis in sight despite countless medical consultations and tests. His significant discovery was made possible by merging whole genome sequencing with the innovative Next-Gen Disease Screen (NGDS), a combination beyond the capability of any other existing test. This powerful approach finally uncovered the genetic culprit: a mutation in the KRT14 gene.
This breakthrough not only provided Dr. Colby with much-needed clarity but also allowed him and his wife to make informed decisions about their family's future, understanding the implications of their genetic makeup. Dr. Colby's experience highlights the transformative impact of NGDS, showcasing its potential to replace fear and uncertainty with empowerment and precise genetic knowledge.
Meet The Families In Need
In honor of Rare Disease Day, we invite you to be part of a special initiative:
For every 50 Rare Disease Day WGS Special Bundles ordered, we pledge to donate a bundle to a family grappling with unresolved health mysteries. These families in need stand to gain invaluable insights from genome sequencing, offering them a beacon of hope in their search for answers.
Meet The Families In Need
In honor of Rare Disease Day, we invite you to be part of a special initiative:
For every 50 Rare Disease Day WGS Special Bundles ordered, we pledge to donate a bundle to a family grappling with unresolved health mysteries. These families in need stand to gain invaluable insights from genome sequencing, offering them a beacon of hope in their search for answers.
DNA tests from 23andMe, AncestryDNA, and most other companies use older technology that produces data on a very small subset of the total genome.
Whole genome sequencing is an entirely different class of technology that tests every letter of your DNA, including all ~30,000 genes and all chromosomes end-to-end.
0.1%
100%
Of Your Genome
Of Your Genome
Free Shipping
HSA/FSA Eligible
+
Free Shipping + HSA/FSA Eligible
© Sequencing.com 2024
© Sequencing.com 2024
Access Sequencing AI
Access Premium Reports
Have a conversation about your DNA and dive deeper into your results
Get Monthly Updates
Monthly Report Credits
We keep you informed on the latest updates on your results
Get credits every month to put toward new reports
Gain access to exclusive reports
Access Sequencing AI
Get Monthly Updates
Monthly Report Credits
Have a conversation about your DNA and dive deeper into your results
Access Premium Reports
We keep you informed on the latest updates on your results
Get credits every month to put toward new reports
Gain access to exclusive reports
Screening Includes The KLK15 Gene Variant, Linked Preliminarily To hEDS*
Understand your risk for Autoimmune Disease by testing 100% of your genome with Whole Genome Sequencing. Learn your predispositions and be proactive about your health journey.
Understand your risk for Autoimmune Disease by testing 100% of your genome with Whole Genome Sequencing. Learn your predispositions and be proactive about your health journey.